Medical Equipment

Injectable Drug Delivery Devices Industry Expansion Forecast Showing Market Size of $79.5 Billion by 2030 at 7.9% CAGR

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Injectable Drug Delivery Devices Market Expected To Change Between 2026 And 2030?

The injectable drug delivery devices market has shown strong expansion over recent years. Its value is anticipated to rise from $54.3 billion in 2025 to $58.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.1%. This historical growth can be attributed to several factors, including the increasing occurrence of chronic diseases, the proliferation of biologics and biosimilars, a rise in hospital-based injectable treatments, enhancements in sterile manufacturing processes, and the broader availability of injection devices.

The injectable drug delivery devices market is projected to experience robust growth in the upcoming years. This market is set to expand to $79.51 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This anticipated expansion during the forecast period is driven by a growing preference for self-administration devices, increasing demand for personalized drug delivery, the enlargement of biologic drug pipelines, rising investments in smart injection technologies, and the broader acceptance of home healthcare solutions. Prominent trends expected in this period include a wider embrace of prefilled and safety syringes, a heightened demand for autoinjectors and pen injectors, the expanding use of home-based injectable therapies, the proliferation of wearable and implantable infusion pumps, and an amplified emphasis on dose precision and patient safety.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2835&type=smp

What Underlying Factors Are Accelerating The Growth Of The Injectable Drug Delivery Devices Market?

The increasing incidence of chronic illnesses is anticipated to boost the growth of the injectable drug delivery devices market. A chronic disease is defined as a long-term condition persisting for at least three months, which may worsen over time. Injectable drug delivery devices provide a dependable and easy way to administer medications over prolonged durations. Such devices can improve patients’ compliance with their treatment plans, facilitating efficient management of chronic ailments and ultimately resulting in improved health outcomes. For example, data from June 2024, released by the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023. This represented an 18% increase from 3,065,825 cases reported in 2022. Consequently, the growing prevalence of chronic diseases is propelling the expansion of the injectable drug delivery devices market moving forward.

How Is The Injectable Drug Delivery Devices Market Structured Across Different Segments?

The injectable drug delivery devices market covered in this report is segmented –

1) By Type: Syringes, Injectors, Pump

2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications

3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users

Subsegments:

1) By Syringes: Conventional Syringes, Prefilled Syringes, Safety Syringes

2) By Injectors: Autoinjectors, Pen Injectors, Needle-Free Injectors

3) By Pumps: Insulin Pumps, Ambulatory Infusion Pumps, Implantable Pumps

Which Trends Are Shaping The Future Of The Injectable Drug Delivery Devices Market?

Leading firms within the injectable drug delivery devices market are prioritizing the creation of sophisticated solutions, including wearable and smart injectors, with the aim of boosting patient ease of use, improving treatment compliance, and enabling individuals to self-administer intricate treatments. These wearable and smart injectors represent cutting-edge systems engineered to precisely dispense medications, such as biologics and high-volume formulations, simultaneously lessening patient discomfort, decreasing the likelihood of user mistakes, and elevating the entire treatment journey. As an illustration, in January 2025, Becton, Dickinson and Company, a US-based medical technology company, unveiled several next-generation devices, including the BD Accuspray Nasal Spray System, BD Hylok Glass Prefillable Syringe, BD Effivax Glass Prefillable Syringe, BD Libertas Wearable Injector, BD Evolve On-body Injector, BD Physioject Disposable Autoinjector, and BD Vystra Disposable Pen. These offerings incorporate easy-to-use designs for self-administration, provide accurate and reliable dosing for biologics and vaccines, are compatible with various drug formulations, and come in wearable designs facilitating the delivery of large volumes, all while maintaining sterility and safety via disposable parts. This introduction highlights the industry’s evolving focus toward sophisticated, patient-oriented injectable drug delivery systems designed to enhance compliance, improve comfort, and optimize treatment results.

Which Major Players Dominate The Injectable Drug Delivery Devices Market?

Major companies operating in the injectable drug delivery devices market are Becton Dickinson and Company, Baxter International, Gerresheimer AG, Catalent Inc., Antares Pharma, Owen Mumford, West Pharmaceutical Services Inc., B. Braun Melsungen AG, Ypsomed AG, AptarGroup Inc., Nemera, Teleflex Medical, Medtronic, Caplin Steriles Limited, Hovione Technology, Jiangsu Delfu Medical Device Co. Ltd., Terumo Corporation, Roche, Sorrel Medical, Novo Nordisk

Read the full injectable drug delivery devices market report here:

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Which Region Is Projected To Dominate The Injectable Drug Delivery Devices Market During The Forecast Period?

North America was the largest region in the injectable drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Injectable Drug Delivery Devices Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2835&type=smp

Browse Through More Reports Similar to the Global Injectable Drug Delivery Devices Market 2026, By The Business Research Company

Glucose Biosensors Market Report 2026

https://www.thebusinessresearchcompany.com/report/glucose-biosensors-global-market-report

Disposable Medical Sensors Market Report 2026

https://www.thebusinessresearchcompany.com/report/disposable-medical-sensors-global-market-report

Disposable Medical Devices Sensors Market Report 2026

https://www.thebusinessresearchcompany.com/report/disposable-medical-devices-sensors-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795